Dr. Marty Makary, the FDA’s commissioner, said in a statement that the “approval represents a significant milestone for ...

Leucovorin is now indicated for adult and pediatric patients with a confirmed variant in the folate receptor 1 gene, the agency said. This disorder affects fewer than one in 1 million people, with ...

In today's Pharmaceutical Executive Daily, the FDA approves leucovorin as the first-ever treatment for an ultra-rare genetic condition called cerebral folate transport deficiency, Enhertu receives FDA ...

Food and Drug Administration Commissioner Marty Makary said in September he was changing leucovorin’s label because it could help “hundreds of thousands” of children with the neurological condition.

NEW YORK – The US Food and Drug Administration on Tuesday approved GSK's Wellcovorin (leucovorin calcium) as a treatment for adult and pediatric patients with cerebral folate deficiency who harbor ...

The Food and Drug Administation is approving a generic drug for a very rare genetic disorder, but not for autism. On Tuesday, the U.S. agency said the drug helps children and adults who cannot ...

The FDA has declined to approve a $2.50 'miracle pill' for autism, despite previously hailing it as a potential treatment for thousands of children.

The Food and Drug Administration approved leucovorin, a drug the Trump administration has touted as a potential therapy for autism, to treat cerebral folate transport deficiency, a neurological ...

About five months after U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr. | About five months after U.S. Health Secretary Robert F. Kennedy Jr. touted leucovorin as “an ...